EAP Versus OLE Study
EAP VERSUS OLE Both an Open Label Extension (OLE) and an Expanded Access Program (EAP) can be used to provide continued treatment access after phase 3 clinical trials have ended.To help companies understand both programs [...]
We are a Pharmaceutical Services Provider that specializes in Drug Development Programs, Treatment Access Solutions and Market Access and Commercialization
We are experienced in Phase I – IV trial delivery with proven track record of excellence supporting 60+ clinical programmes worldwide.
We are experienced in Phase I – IV trial delivery with proven track record of excellence supporting 60+ clinical programmes worldwide.
Industry leader with over 16 years of experience designing and deliveing calue-driven Expanded Access (EAPs) and Post-Trial Access Programs.
EAP VERSUS OLE Both an Open Label Extension (OLE) and an Expanded Access Program (EAP) can be used to provide continued treatment access after phase 3 clinical trials have ended.To help companies understand both programs [...]